SaferWorldbyDesign Webinar: Use of alternative skin models for animal-free safety and efficacy testing in dermatology research

Tuesday 11 August 2020

16-16:45 CEST - (7 am California, 10 am New York, 3 pm London, 4 pm Zurich, 7:30 pm New Delhi, 11 pm Tokyo)

This virtual meeting will include a perspective by Hanan Osman-Ponchet (Founder & President, PKDERM) followed by a discussion session.

A set of alternative in vitro and ex vivo skin models can be used to evaluate the safety and efficacy of topical products. For example, 2D-cell culture derived from human skin can be used to evaluate anti-inflammatory, anti-aging, skin pigmentation, wound healing, or to predict skin sensitization of active molecules. On the other hand, 3D-human reconstructed skin models can be used to evaluate skin irritation (safety), skin sensitization (safety), or even anti-inflammatory properties (efficacy) of topical products. Excised human skin model, on the other hand, is used as the gold standard to evaluate dermal absorption, skin metabolism, and drug transporters, since dermal absorption data are of importance in toxicological risk assessment.

But what is the most appropriate skin model to be used for specific assessment of safety and efficacy in dermatology based on the development stage?

In this webinar, an overview of the in vitro alternative skin models will be presented with practical examples on the advantages and limitations of each model in safety and efficacy assessment, with a focus on dermal absorption and inflammation testing.

Latest Tweets

Edelweiss Connect (4 weeks ago)
#OpenTox Virtual Summer School 25 - 29 July 2022 Topics: QSAR Modelling Toxicogenomics Analysis Integrated Appro… https://t.co/Ep4afFQxL2
Edelweiss Connect (4 weeks ago)
Join us for the first part of an ongoing #SaferWorldbyDesign series: Working days of a cosmetic safety assessor in… https://t.co/ERrcaF5P0J
Edelweiss Connect (3 months ago)
Join us on May 10 for another #SaferWorldbyDesign webinar and discussion: Using Transcriptomics Data in Risk Assess… https://t.co/DFTVFy3bXN
Edelweiss Connect (4 months ago)
RT @barryhardy: Semi-automated approach for generation of biological networks on drug-induced cholestasis, steatosis, hepatitis, and cirrho…
Edelweiss Connect (4 months ago)
Check out the latest #HepaRG newsletter from #SaferWorldbyDesign https://t.co/zzSZ87yOZ6 https://t.co/aGGTbhrvn5

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA